Medivia Lifesciences formulates and manufactures branded generic medicines built to the same therapeutic standards as leading brands — backed by rigorous quality control, modern infrastructure, and a commitment to accessible healthcare.
Founded with the mission to bridge the gap between cost and quality, Medivia Lifesciences manufactures a wide range of branded generic formulations within a WHO-GMP compliant facility. Our medicines reach hospitals, clinics and pharmacies through a reliable, growing distribution network.
Every formulation we release carries the same rigour in raw material sourcing, process validation and finished-product testing — so healthcare providers can recommend with confidence and patients can take with trust.
Branded generic medicines combine proven pharmaceutical science with accessible pricing — without compromising on the standards healthcare relies on.
Our formulations contain the same active pharmaceutical ingredient, in the same strength, as the original branded composition.
Every batch passes through in-house quality control checks before it is cleared for dispatch to our partners.
By optimising manufacturing efficiency, we help make effective treatment options reachable for a wider patient base.
From formulation science to last-mile distribution, our teams bring focused expertise to every stage of the medicine lifecycle.
Developing stable, bioequivalent formulations across tablets, capsules, syrups and topicals.
Manufacturing practices aligned with national pharmaceutical regulations and quality directives.
Modern production lines designed for consistency, hygiene and validated batch output.
Dedicated QC laboratories examine every batch against defined pharmacopoeial standards.
A growing network of stockists and distributors ensures consistent product availability.
Working closely with hospitals, clinics and pharmacies to understand and serve patient needs.
Quality at Medivia Lifesciences is not a final checkpoint — it is built into raw material selection, in-process monitoring and final release testing, governed by trained quality personnel and validated systems.
Our facility is equipped to manufacture across multiple dosage forms, each governed by dedicated process protocols.
Coated and uncoated tablet lines with automated weight and hardness checks.
Hard-gelatin capsule filling with precise dosing and visual inspection.
Oral liquid manufacturing with controlled mixing and microbial testing.
Dry powder blending and sachet filling for nutraceutical formulations.
Our R&D team works on formulation development and evaluation, ensuring every product meets defined performance and stability benchmarks before it reaches a manufacturing line.
Our manufacturing practices are aligned with recognised pharmaceutical quality and environmental management standards.
Every formulation is tested against defined pharmacopoeial benchmarks.
250+ formulations spanning nine therapeutic categories.
A distribution network spanning 20+ states and growing.
Leadership with deep roots in pharmaceutical manufacturing.
Consistent batch planning to avoid supply disruptions.
A responsive team for healthcare partner queries and onboarding.